Credit rating agency, CARE has assigned BB- rating to Syschem India’s long-term bank facilities worth Rs 15.75 crore. The rating agency has also assigned A4 rating to the company’s short term bank facilities worth Rs 3.00 crore.
The company has received the said rating on the back of its small scale of operations, working capital intensive nature of its business, high fragmentation and high level of competition in each product line.
Syschem India is engaged in the business of manufacturing of Active Pharmaceutical Ingredient Intermediates (API Intermediate), thinners, wood and paint finishes and distillation of solvents.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: